ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 080,36
-0,27%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Corbus Pharmaceuticals Holdings Inc (CRBP)

  7. Corbus Pharmaceuticals Holdings Inc (CRBP) Actualités

CRBP

Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CRBP
DateHeureSourceTitreSymboleSociété
20/05/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
20/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/05/202422h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202423h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422h41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/02/202423h09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
31/01/202415h16Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202413h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
13/06/202322h59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/06/202322h54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/06/202312h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/05/202322h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
19/05/202315h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/05/202323h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202322h32Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202322h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
10/03/202322h32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202322h30Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202316h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
15/02/202312h07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/11/202223h51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/11/202212h25TipRanksCorbus Pharmaceuticals (CRBP) Gets a Buy from H.C. WainwrightNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/10/202214h05PR Newswire (US)Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/10/202223h09Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
26/09/202214h05PR Newswire (US)Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of DirectorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/09/202214h00PR Newswire (US)Corbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/09/202213h00PR Newswire (US)Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRBP

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
ORA
Orange
EU
CAP
Capgemini
EU
PX1
CAC 40
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
EU
BNP
BNP Paribas
NASDAQ
MSFT
Microsoft
EU
AF
Air FranceKLM
EU
RI
Pernod Ricard
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés